Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study To Monitor Lung Cancer Patients Activity And Assess Performance Status Through A Wearable Device.

NCT04751162 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT04751162
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04751162 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study To Monitor Lung Cancer Patients Activity And Assess Performance Status Through A Wearable Device.
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
February 18, 2021
Completion date
May 1, 2023
Enrollment
71 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer (nsclc)